As "uvula bifida" physician denote the longitudinal splitting of the uvula. It can be an indication of a PGM1 deficiency
The disease can be easily recognized by looking into the mouth: most patients have a split uvula. The disease can be severe and affect the heart, the muscles, the liver and many other organs. Further research revealed a novel therapy: galactose can successfully be applied to treat patients. The main source of galactose is lactose, better known as milk sugar.Scientific background
A group of patients was identified with defects in this enzyme leading to a multitude of clinical symptoms. Project leader Thorsten Marquardt, University’s Children Hospital Münster: "Patients present with muscle pain or red urine after exercise, liver disease with low blood sugar levels, heart failure and other symptoms. This reflects the multitude of pathways that is linked to PGM1. But most importantly, patients can be readily identified by the presence of a split uvula which can easily be found by inspection of the mouth.” Dirk Lefeber, Radboud University Medical Center and co-leader of the project: “Innovative technology allowed us to analyze the precise glycan structures on blood proteins. This resulted in a specific biomarker that can now be applied to quickly diagnose patients with a simple blood test. The research not only linked energy metabolism with protein glycosylation via PGM1, but also highlighted important features of disease pathology.”Personalized treatment using the sugar galactose
Radboud university medical center is an institute for patient care, research and education & training, located in Nijmegen. Our mission is to have a significant impact on healthcare. We aim to be a frontrunner in the development of innovative, sustainable and affordable healthcare. By offering excellent quality, participatory and personalised healthcare, operational excellence and sustainable networks. Our almost 10,000 employees and over 3,000 students do their utmost every day to make a positive contribution to the future of healthcare and medical sciences.
Here in the University Medicine Münster the manifold specialized competences of the University Hospital Münster (UKM) and the University Münster (WWU) meet. The UKM as a maximum care hospital with a capacity of 1,457 beds and more than 30 clinics delivers best-in-class medicine and high performance medical care to round about 56,000 ambulant patients as well as to 464,000 in-patient cases. Excellent research is conducted here by 2,000 scientists and the medical training of round about 3,000 future medical doctors is carried out at the Medical Faculty of the University Münster. Thanks to the close cooperation of both institutes the results gained from the research at the Medical Faculty are directly passed on to the health care of the University Hospital Münster.
Thomas Bauer | idw
'Sugar-coated' microcapsule eliminates toxic punch of experimental anti-cancer drug
18.12.2014 | Johns Hopkins Medicine
Fine particulate air pollution linked with increased autism risk
18.12.2014 | Harvard School of Public Health
08.12.2014 | Event News
01.12.2014 | Event News
21.11.2014 | Event News
18.12.2014 | Life Sciences
18.12.2014 | Life Sciences
18.12.2014 | Materials Sciences